Abstract
To determine whether reductions in psychiatric hospitalizations with early initiation of paliperidone palmitate (PP) versus oral antipsychotic (OAP) therapy observed in a DREaM post hoc analysis are reproducible in real-world patients with recent-onset schizophrenia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have